Plasma myosin-11 levels did not differ between patients with CAD and PAD, and circulating myosin-11 levels were higher in the CAD + PAD group than in the CAD or PAD group, suggesting that a higher level of circulating myosin-11 is associated with the presence of multiple atherosclerotic regions. Here, MYH11 is linked to coronary artery disorder.